FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a novel drug delivery and specialty pharmaceutical company, announced the appointment of Mark J. Baric as a Director to the NovaDel Board of Directors effective February 1, 2007. Mr. Baric is the President and Co-founder of CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system.
